Corcept Therapeutics, Inc. (CORT)
72.96
-0.75
(-1.02%)
USD |
NASDAQ |
Nov 13, 16:00
72.96
0.00 (0.00%)
After-Hours: 16:53
Corcept Therapeutics Price : 72.96 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 72.23 | 75.50 | 72.23 | 73.71 | 847073.0 |
| Nov 11, 2026 | 74.39 | 75.92 | 73.72 | 74.53 | 1.116M |
| Nov 10, 2026 | 74.07 | 76.50 | 71.57 | 73.35 | 1.341M |
| Nov 09, 2026 | 73.31 | 76.58 | 70.51 | 75.02 | 1.654M |
| Nov 06, 2026 | 73.60 | 74.86 | 72.17 | 72.77 | 1.407M |
| Nov 05, 2026 | 77.88 | 78.99 | 71.52 | 71.63 | 1.508M |
| Nov 04, 2026 | 84.98 | 84.98 | 71.29 | 79.22 | 2.196M |
| Nov 03, 2026 | 80.92 | 84.19 | 80.92 | 81.93 | 1.524M |
| Nov 02, 2026 | 80.93 | 82.23 | 79.40 | 80.46 | 1.593M |
| Oct 30, 2026 | 85.00 | 85.30 | 80.28 | 81.12 | 1.429M |
| Oct 29, 2026 | 86.07 | 88.01 | 85.21 | 85.95 | 1.186M |
| Oct 28, 2026 | 86.43 | 88.59 | 86.00 | 86.28 | 1.048M |
| Oct 27, 2026 | 85.31 | 87.97 | 84.91 | 87.59 | 925519.0 |
| Oct 26, 2026 | 86.10 | 91.78 | 85.86 | 87.12 | 1.872M |
| Oct 23, 2026 | 106.05 | 106.09 | 84.13 | 85.86 | 3.099M |
| Oct 22, 2026 | 115.16 | 115.73 | 107.33 | 107.50 | 809884.0 |
| Oct 21, 2026 | 116.45 | 118.42 | 116.10 | 116.28 | 516766.0 |
| Oct 20, 2026 | 112.60 | 117.14 | 111.96 | 116.45 | 549571.0 |
| Oct 19, 2026 | 111.70 | 113.09 | 110.50 | 112.10 | 392850.0 |
| Oct 16, 2026 | 113.17 | 113.64 | 107.79 | 110.16 | 849971.0 |
| Oct 15, 2026 | 116.31 | 117.48 | 113.02 | 113.37 | 668517.0 |
| Oct 14, 2026 | 117.94 | 122.21 | 115.95 | 116.23 | 691964.0 |
| Oct 13, 2026 | 121.83 | 122.81 | 117.42 | 117.80 | 556292.0 |
| Oct 12, 2026 | 121.24 | 122.09 | 119.28 | 121.19 | 497735.0 |
| Oct 09, 2026 | 118.00 | 122.34 | 117.41 | 121.19 | 624209.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 28.90 |
| Phibro Animal Health Corp. | 35.98 |
| Illumina, Inc. | 207.03 |
| Eli Lilly & Co. | 1444.57 |
| Merck & Co., Inc. | 147.74 |
Price Related Metrics
| PE Ratio | 57.58 |
| PS Ratio | 8.818 |
| PEG Ratio | 1.286 |
| Price to Book Value | 9.570 |
| Price to Free Cash Flow | 43.66 |
| Earnings Yield | 1.74% |
| Market Cap | 7.979B |
| PEGY Ratio | 1.286 |
| Operating PE Ratio | 76.62 |
| Normalized PE Ratio | 57.58 |